English
简体中文
Total: £ 56.28
Published Date: 2026-04-24 | Pages: 180 | Tables: 172 | Service & Software
The global Microphysiological System market was valued at US$ 150 million in 2025 and is anticipated to reach US$ 424 million by 2032, at a CAGR of 16.2% from 2026 to 2032.
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
The global key companies of Microphysiological System include Emulate, Mimetas, InSphero, TissUse, CN Bio, Valo Health (TARA Biosystems), Hesperos, TNO, 28bio, Newcells Biotech, etc. In 2024, the global five largest players hold a share approximately 48.81% in terms of revenue.
Due to better policy and financial support in European countries and USA and earlier research, the overall industry of microphysiological system has developed rapidly, and the industrialization process in other regions such as Asia is lagging behind.
It is worth noting that because the microphysiological system industry is still in the early stages of development, and the mid-stream and downstream demand has not yet increased, many microphysiological system companies play an upstream role to some extent and mostly conduct organoid and organ-on-chip research on their own. Research and development of chip automation, high-throughput operating instruments and imaging equipment.
With the further development of the industry in the future and the implementation of relevant policies and standards, the industry's demand for upstream will increase, which will promote the birth of more professional upstream companies and the business transformation of some microphysiological system companies.
This report delivers a comprehensive overview of the global Microphysiological System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Microphysiological System. The Microphysiological System market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Microphysiological System market comprehensively. Regional market sizes by Type, by End User, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Microphysiological System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by End User, and by region.
Market Segmentation
By Company
Emulate
Mimetas
TissUse
InSphero
Hesperos
CN Bio
TNO
28bio
Beijing Daxiang Biotech
Newcells Biotech
Nortis (Quris-Al)
Valo Health (TARA Biosystems)
Altis Biosystems
Draper Laboratory
Netri
Bi/ond
ImmuONE
AlveoliX
Cherry Biotech
Ananda Devices
Obatala Sciences
BiomimX
React4life
Aracari Bio
StemPharm
SynVivo
Segment by Type
Human Organ and Tissue Models
Disease Models
Non-Human Species Models
Segment by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by End User, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Microphysiological System companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by End User, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microphysiological System Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Human Organ and Tissue Models
1.2.3 Disease Models
1.2.4 Non-Human Species Models
1.3 Market by End User
1.3.1 Global Microphysiological System Market Growth by End User: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microphysiological System Market Perspective (2021–2032)
2.2 Global Microphysiological System Growth Trends by Region
2.2.1 Global Microphysiological System Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Microphysiological System Historic Market Size by Region (2021–2026)
2.2.3 Microphysiological System Forecasted Market Size by Region (2027–2032)
2.3 Microphysiological System Market Dynamics
2.3.1 Microphysiological System Industry Trends
2.3.2 Microphysiological System Market Drivers
2.3.3 Microphysiological System Market Challenges
2.3.4 Microphysiological System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microphysiological System Players by Revenue
3.1.1 Global Top Microphysiological System Players by Revenue (2021–2026)
3.1.2 Global Microphysiological System Revenue Market Share by Players (2021–2026)
3.2 Global Top Microphysiological System Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Microphysiological System Revenue
3.4 Global Microphysiological System Market Concentration Ratio
3.4.1 Global Microphysiological System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microphysiological System Revenue in 2025
3.5 Global Key Players of Microphysiological System Head Offices and Areas Served
3.6 Global Key Players of Microphysiological System, Products and Applications
3.7 Global Key Players of Microphysiological System, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Microphysiological System Breakdown Data by Type
4.1 Global Microphysiological System Historic Market Size by Type (2021–2026)
4.2 Global Microphysiological System Forecasted Market Size by Type (2027–2032)
5 Microphysiological System Breakdown Data by End User
5.1 Global Microphysiological System Historic Market Size by End User (2021–2026)
5.2 Global Microphysiological System Forecasted Market Size by End User (2027–2032)
6 North America
6.1 North America Microphysiological System Market Size (2021–2032)
6.2 North America Microphysiological System Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Microphysiological System Market Size by Country (2021–2026)
6.4 North America Microphysiological System Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microphysiological System Market Size (2021–2032)
7.2 Europe Microphysiological System Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Microphysiological System Market Size by Country (2021–2026)
7.4 Europe Microphysiological System Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Microphysiological System Market Size (2021–2032)
8.2 Asia-Pacific Microphysiological System Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Microphysiological System Market Size by Region (2021–2026)
8.4 Asia-Pacific Microphysiological System Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Microphysiological System Market Size (2021–2032)
9.2 Latin America Microphysiological System Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Microphysiological System Market Size by Country (2021–2026)
9.4 Latin America Microphysiological System Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microphysiological System Market Size (2021–2032)
10.2 Middle East & Africa Microphysiological System Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Microphysiological System Market Size by Country (2021–2026)
10.4 Middle East & Africa Microphysiological System Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emulate
11.1.1 Emulate Company Details
11.1.2 Emulate Business Overview
11.1.3 Emulate Microphysiological System Introduction
11.1.4 Emulate Revenue in Microphysiological System Business (2021–2026)
11.1.5 Emulate Recent Development
11.2 Mimetas
11.2.1 Mimetas Company Details
11.2.2 Mimetas Business Overview
11.2.3 Mimetas Microphysiological System Introduction
11.2.4 Mimetas Revenue in Microphysiological System Business (2021–2026)
11.2.5 Mimetas Recent Development
11.3 TissUse
11.3.1 TissUse Company Details
11.3.2 TissUse Business Overview
11.3.3 TissUse Microphysiological System Introduction
11.3.4 TissUse Revenue in Microphysiological System Business (2021–2026)
11.3.5 TissUse Recent Development
11.4 InSphero
11.4.1 InSphero Company Details
11.4.2 InSphero Business Overview
11.4.3 InSphero Microphysiological System Introduction
11.4.4 InSphero Revenue in Microphysiological System Business (2021–2026)
11.4.5 InSphero Recent Development
11.5 Hesperos
11.5.1 Hesperos Company Details
11.5.2 Hesperos Business Overview
11.5.3 Hesperos Microphysiological System Introduction
11.5.4 Hesperos Revenue in Microphysiological System Business (2021–2026)
11.5.5 Hesperos Recent Development
11.6 CN Bio
11.6.1 CN Bio Company Details
11.6.2 CN Bio Business Overview
11.6.3 CN Bio Microphysiological System Introduction
11.6.4 CN Bio Revenue in Microphysiological System Business (2021–2026)
11.6.5 CN Bio Recent Development
11.7 TNO
11.7.1 TNO Company Details
11.7.2 TNO Business Overview
11.7.3 TNO Microphysiological System Introduction
11.7.4 TNO Revenue in Microphysiological System Business (2021–2026)
11.7.5 TNO Recent Development
11.8 28bio
11.8.1 28bio Company Details
11.8.2 28bio Business Overview
11.8.3 28bio Microphysiological System Introduction
11.8.4 28bio Revenue in Microphysiological System Business (2021–2026)
11.8.5 28bio Recent Development
11.9 Beijing Daxiang Biotech
11.9.1 Beijing Daxiang Biotech Company Details
11.9.2 Beijing Daxiang Biotech Business Overview
11.9.3 Beijing Daxiang Biotech Microphysiological System Introduction
11.9.4 Beijing Daxiang Biotech Revenue in Microphysiological System Business (2021–2026)
11.9.5 Beijing Daxiang Biotech Recent Development
11.10 Newcells Biotech
11.10.1 Newcells Biotech Company Details
11.10.2 Newcells Biotech Business Overview
11.10.3 Newcells Biotech Microphysiological System Introduction
11.10.4 Newcells Biotech Revenue in Microphysiological System Business (2021–2026)
11.10.5 Newcells Biotech Recent Development
11.11 Nortis (Quris-Al)
11.11.1 Nortis (Quris-Al) Company Details
11.11.2 Nortis (Quris-Al) Business Overview
11.11.3 Nortis (Quris-Al) Microphysiological System Introduction
11.11.4 Nortis (Quris-Al) Revenue in Microphysiological System Business (2021–2026)
11.11.5 Nortis (Quris-Al) Recent Development
11.12 Valo Health (TARA Biosystems)
11.12.1 Valo Health (TARA Biosystems) Company Details
11.12.2 Valo Health (TARA Biosystems) Business Overview
11.12.3 Valo Health (TARA Biosystems) Microphysiological System Introduction
11.12.4 Valo Health (TARA Biosystems) Revenue in Microphysiological System Business (2021–2026)
11.12.5 Valo Health (TARA Biosystems) Recent Development
11.13 Altis Biosystems
11.13.1 Altis Biosystems Company Details
11.13.2 Altis Biosystems Business Overview
11.13.3 Altis Biosystems Microphysiological System Introduction
11.13.4 Altis Biosystems Revenue in Microphysiological System Business (2021–2026)
11.13.5 Altis Biosystems Recent Development
11.14 Draper Laboratory
11.14.1 Draper Laboratory Company Details
11.14.2 Draper Laboratory Business Overview
11.14.3 Draper Laboratory Microphysiological System Introduction
11.14.4 Draper Laboratory Revenue in Microphysiological System Business (2021–2026)
11.14.5 Draper Laboratory Recent Development
11.15 Netri
11.15.1 Netri Company Details
11.15.2 Netri Business Overview
11.15.3 Netri Microphysiological System Introduction
11.15.4 Netri Revenue in Microphysiological System Business (2021–2026)
11.15.5 Netri Recent Development
11.16 Bi/ond
11.16.1 Bi/ond Company Details
11.16.2 Bi/ond Business Overview
11.16.3 Bi/ond Microphysiological System Introduction
11.16.4 Bi/ond Revenue in Microphysiological System Business (2021–2026)
11.16.5 Bi/ond Recent Development
11.17 ImmuONE
11.17.1 ImmuONE Company Details
11.17.2 ImmuONE Business Overview
11.17.3 ImmuONE Microphysiological System Introduction
11.17.4 ImmuONE Revenue in Microphysiological System Business (2021–2026)
11.17.5 ImmuONE Recent Development
11.18 AlveoliX
11.18.1 AlveoliX Company Details
11.18.2 AlveoliX Business Overview
11.18.3 AlveoliX Microphysiological System Introduction
11.18.4 AlveoliX Revenue in Microphysiological System Business (2021–2026)
11.18.5 AlveoliX Recent Development
11.19 Cherry Biotech
11.19.1 Cherry Biotech Company Details
11.19.2 Cherry Biotech Business Overview
11.19.3 Cherry Biotech Microphysiological System Introduction
11.19.4 Cherry Biotech Revenue in Microphysiological System Business (2021–2026)
11.19.5 Cherry Biotech Recent Development
11.20 Ananda Devices
11.20.1 Ananda Devices Company Details
11.20.2 Ananda Devices Business Overview
11.20.3 Ananda Devices Microphysiological System Introduction
11.20.4 Ananda Devices Revenue in Microphysiological System Business (2021–2026)
11.20.5 Ananda Devices Recent Development
11.21 Obatala Sciences
11.21.1 Obatala Sciences Company Details
11.21.2 Obatala Sciences Business Overview
11.21.3 Obatala Sciences Microphysiological System Introduction
11.21.4 Obatala Sciences Revenue in Microphysiological System Business (2021–2026)
11.21.5 Obatala Sciences Recent Development
11.22 BiomimX
11.22.1 BiomimX Company Details
11.22.2 BiomimX Business Overview
11.22.3 BiomimX Microphysiological System Introduction
11.22.4 BiomimX Revenue in Microphysiological System Business (2021–2026)
11.22.5 BiomimX Recent Development
11.23 React4life
11.23.1 React4life Company Details
11.23.2 React4life Business Overview
11.23.3 React4life Microphysiological System Introduction
11.23.4 React4life Revenue in Microphysiological System Business (2021–2026)
11.23.5 React4life Recent Development
11.24 Aracari Bio
11.24.1 Aracari Bio Company Details
11.24.2 Aracari Bio Business Overview
11.24.3 Aracari Bio Microphysiological System Introduction
11.24.4 Aracari Bio Revenue in Microphysiological System Business (2021–2026)
11.24.5 Aracari Bio Recent Development
11.25 StemPharm
11.25.1 StemPharm Company Details
11.25.2 StemPharm Business Overview
11.25.3 StemPharm Microphysiological System Introduction
11.25.4 StemPharm Revenue in Microphysiological System Business (2021–2026)
11.25.5 StemPharm Recent Development
11.26 SynVivo
11.26.1 SynVivo Company Details
11.26.2 SynVivo Business Overview
11.26.3 SynVivo Microphysiological System Introduction
11.26.4 SynVivo Revenue in Microphysiological System Business (2021–2026)
11.26.5 SynVivo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Microphysiological System Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Human Organ and Tissue Models
Table 3. Key Players of Disease Models
Table 4. Key Players of Non-Human Species Models
Table 5. Global Microphysiological System Market Size Growth by End User (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Microphysiological System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Microphysiological System Market Size by Region (US$ Million), 2021–2026
Table 8. Global Microphysiological System Market Share by Region (2021–2026)
Table 9. Global Microphysiological System Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Microphysiological System Market Share by Region (2027–2032)
Table 11. Microphysiological System Market Trends
Table 12. Microphysiological System Market Drivers
Table 13. Microphysiological System Market Challenges
Table 14. Microphysiological System Market Restraints
Table 15. Global Microphysiological System Revenue by Players (US$ Million), 2021–2026
Table 16. Global Microphysiological System Market Share by Players (2021–2026)
Table 17. Global Top Microphysiological System Players by Tier (Tier 1, Tier 2, and Tier 3), based on Microphysiological System Revenue, 2025
Table 18. Ranking of Global Top Microphysiological System Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Microphysiological System Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Microphysiological System, Headquarters and Area Served
Table 21. Global Key Players of Microphysiological System, Products and Applications
Table 22. Global Key Players of Microphysiological System, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Microphysiological System Market Size by Type (US$ Million), 2021–2026
Table 25. Global Microphysiological System Revenue Market Share by Type (2021–2026)
Table 26. Global Microphysiological System Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Microphysiological System Revenue Market Share by Type (2027–2032)
Table 28. Global Microphysiological System Market Size by End User (US$ Million), 2021–2026
Table 29. Global Microphysiological System Revenue Market Share by End User (2021–2026)
Table 30. Global Microphysiological System Forecasted Market Size by End User (US$ Million), 2027–2032
Table 31. Global Microphysiological System Revenue Market Share by End User (2027–2032)
Table 32. North America Microphysiological System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Microphysiological System Market Size by Country (US$ Million), 2021–2026
Table 34. North America Microphysiological System Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Microphysiological System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Microphysiological System Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Microphysiological System Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Microphysiological System Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Microphysiological System Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Microphysiological System Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Microphysiological System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Microphysiological System Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Microphysiological System Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Microphysiological System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Microphysiological System Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Microphysiological System Market Size by Country (US$ Million), 2027–2032
Table 47. Emulate Company Details
Table 48. Emulate Business Overview
Table 49. Emulate Microphysiological System Product
Table 50. Emulate Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 51. Emulate Recent Development
Table 52. Mimetas Company Details
Table 53. Mimetas Business Overview
Table 54. Mimetas Microphysiological System Product
Table 55. Mimetas Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 56. Mimetas Recent Development
Table 57. TissUse Company Details
Table 58. TissUse Business Overview
Table 59. TissUse Microphysiological System Product
Table 60. TissUse Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 61. TissUse Recent Development
Table 62. InSphero Company Details
Table 63. InSphero Business Overview
Table 64. InSphero Microphysiological System Product
Table 65. InSphero Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 66. InSphero Recent Development
Table 67. Hesperos Company Details
Table 68. Hesperos Business Overview
Table 69. Hesperos Microphysiological System Product
Table 70. Hesperos Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 71. Hesperos Recent Development
Table 72. CN Bio Company Details
Table 73. CN Bio Business Overview
Table 74. CN Bio Microphysiological System Product
Table 75. CN Bio Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 76. CN Bio Recent Development
Table 77. TNO Company Details
Table 78. TNO Business Overview
Table 79. TNO Microphysiological System Product
Table 80. TNO Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 81. TNO Recent Development
Table 82. 28bio Company Details
Table 83. 28bio Business Overview
Table 84. 28bio Microphysiological System Product
Table 85. 28bio Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 86. 28bio Recent Development
Table 87. Beijing Daxiang Biotech Company Details
Table 88. Beijing Daxiang Biotech Business Overview
Table 89. Beijing Daxiang Biotech Microphysiological System Product
Table 90. Beijing Daxiang Biotech Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 91. Beijing Daxiang Biotech Recent Development
Table 92. Newcells Biotech Company Details
Table 93. Newcells Biotech Business Overview
Table 94. Newcells Biotech Microphysiological System Product
Table 95. Newcells Biotech Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 96. Newcells Biotech Recent Development
Table 97. Nortis (Quris-Al) Company Details
Table 98. Nortis (Quris-Al) Business Overview
Table 99. Nortis (Quris-Al) Microphysiological System Product
Table 100. Nortis (Quris-Al) Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 101. Nortis (Quris-Al) Recent Development
Table 102. Valo Health (TARA Biosystems) Company Details
Table 103. Valo Health (TARA Biosystems) Business Overview
Table 104. Valo Health (TARA Biosystems) Microphysiological System Product
Table 105. Valo Health (TARA Biosystems) Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 106. Valo Health (TARA Biosystems) Recent Development
Table 107. Altis Biosystems Company Details
Table 108. Altis Biosystems Business Overview
Table 109. Altis Biosystems Microphysiological System Product
Table 110. Altis Biosystems Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 111. Altis Biosystems Recent Development
Table 112. Draper Laboratory Company Details
Table 113. Draper Laboratory Business Overview
Table 114. Draper Laboratory Microphysiological System Product
Table 115. Draper Laboratory Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 116. Draper Laboratory Recent Development
Table 117. Netri Company Details
Table 118. Netri Business Overview
Table 119. Netri Microphysiological System Product
Table 120. Netri Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 121. Netri Recent Development
Table 122. Bi/ond Company Details
Table 123. Bi/ond Business Overview
Table 124. Bi/ond Microphysiological System Product
Table 125. Bi/ond Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 126. Bi/ond Recent Development
Table 127. ImmuONE Company Details
Table 128. ImmuONE Business Overview
Table 129. ImmuONE Microphysiological System Product
Table 130. ImmuONE Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 131. ImmuONE Recent Development
Table 132. AlveoliX Company Details
Table 133. AlveoliX Business Overview
Table 134. AlveoliX Microphysiological System Product
Table 135. AlveoliX Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 136. AlveoliX Recent Development
Table 137. Cherry Biotech Company Details
Table 138. Cherry Biotech Business Overview
Table 139. Cherry Biotech Microphysiological System Product
Table 140. Cherry Biotech Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 141. Cherry Biotech Recent Development
Table 142. Ananda Devices Company Details
Table 143. Ananda Devices Business Overview
Table 144. Ananda Devices Microphysiological System Product
Table 145. Ananda Devices Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 146. Ananda Devices Recent Development
Table 147. Obatala Sciences Company Details
Table 148. Obatala Sciences Business Overview
Table 149. Obatala Sciences Microphysiological System Product
Table 150. Obatala Sciences Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 151. Obatala Sciences Recent Development
Table 152. BiomimX Company Details
Table 153. BiomimX Business Overview
Table 154. BiomimX Microphysiological System Product
Table 155. BiomimX Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 156. BiomimX Recent Development
Table 157. React4life Company Details
Table 158. React4life Business Overview
Table 159. React4life Microphysiological System Product
Table 160. React4life Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 161. React4life Recent Development
Table 162. Aracari Bio Company Details
Table 163. Aracari Bio Business Overview
Table 164. Aracari Bio Microphysiological System Product
Table 165. Aracari Bio Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 166. Aracari Bio Recent Development
Table 167. StemPharm Company Details
Table 168. StemPharm Business Overview
Table 169. StemPharm Microphysiological System Product
Table 170. StemPharm Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 171. StemPharm Recent Development
Table 172. SynVivo Company Details
Table 173. SynVivo Business Overview
Table 174. SynVivo Microphysiological System Product
Table 175. SynVivo Revenue in Microphysiological System Business (US$ Million), 2021–2026
Table 176. SynVivo Recent Development
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
Table 180. Authors List of This Report
List of Figures
Figure 1. Microphysiological System Picture
Figure 2. Global Microphysiological System Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Microphysiological System Market Share by Type: 2025 vs 2032
Figure 4. Human Organ and Tissue Models Features
Figure 5. Disease Models Features
Figure 6. Non-Human Species Models Features
Figure 7. Global Microphysiological System Market Size by End User (US$ Million), 2021–2032
Figure 8. Global Microphysiological System Market Share by End User: 2025 vs 2032
Figure 9. Pharmaceutical & Biotechnology Companies Case Studies
Figure 10. Academic & Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Microphysiological System Report Years Considered
Figure 13. Global Microphysiological System Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Microphysiological System Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Microphysiological System Market Share by Region: 2025 vs 2032
Figure 16. Global Microphysiological System Market Share by Players in 2025
Figure 17. Global Microphysiological System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Microphysiological System Revenue in 2025
Figure 19. North America Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Microphysiological System Market Share by Country (2021–2032)
Figure 21. United States Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Microphysiological System Market Share by Country (2021–2032)
Figure 25. Germany Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Microphysiological System Market Share by Region (2021–2032)
Figure 33. China Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Microphysiological System Market Share by Country (2021–2032)
Figure 41. Mexico Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Microphysiological System Market Share by Country (2021–2032)
Figure 45. Israel Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Microphysiological System Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Emulate Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 49. Mimetas Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 50. TissUse Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 51. InSphero Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 52. Hesperos Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 53. CN Bio Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 54. TNO Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 55. 28bio Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 56. Beijing Daxiang Biotech Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 57. Newcells Biotech Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 58. Nortis (Quris-Al) Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 59. Valo Health (TARA Biosystems) Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 60. Altis Biosystems Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 61. Draper Laboratory Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 62. Netri Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 63. Bi/ond Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 64. ImmuONE Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 65. AlveoliX Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 66. Cherry Biotech Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 67. Ananda Devices Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 68. Obatala Sciences Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 69. BiomimX Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 70. React4life Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 71. Aracari Bio Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 72. StemPharm Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 73. SynVivo Revenue Growth Rate in Microphysiological System Business (2021–2026)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
